herenciageneticayenfermedad: Monoclonal Antibodies versus Polyclonal Antibodies

miércoles, 24 de octubre de 2018

Monoclonal Antibodies versus Polyclonal Antibodies

	October 24, 2018
	Antibodies
	The latest antibodies news from News Medical

Gold standard IHC markers

Find out about the benefits of Abcam's range of IHC-optimized recombinant rabbit monoclonal SP clones, specifically developed for use in pathology and cancer research. They are made using the same technology as the existing RabMAb® antibodies, ensuring lot-to-lot consistency, specificity, and sensitivity.

A Single Platform to Sequence All Monoclonal Antibody Proteins

Having a single platform to sequence all monoclonal antibody proteins provides researchers with the important pieces of information they need to know at an early stage of antibody drug discovery, research and development processes.

Learn More

Antibody Purification Techniques

This article describes the techniques used in the purification of monoclonal and polyclonal antibodies from a serum sample.

	Antibody-Drug Conjugates: History and Development Antibody-drug conjugates allow the targeted delivery of a specific drug dose to the site of interest. They are most commonly employed in oncology, where a high drug dose is required at the tumor site, but not the surrounding tissue.

	Monoclonal Antibodies versus Polyclonal Antibodies Antibodies are glycoproteins that bind to antigens (such as those of bacterial or viral origin) to eliminate or neutralize them. Polyclonal antibodies recognize multiple epitopes, whereas monoclonal antibodies only recognize one.

	Broadly neutralizing antibodies offer a new approach to treating HIV infection A new generation of broadly neutralizing antibodies provides a novel approach to treating HIV infection.

	Panel of human antibodies developed to neutralize black mamba snake toxin IONTAS Limited, a leader in the discovery and optimisation of fully human antibodies, today announced a collaborative paper published in Nature Communications with the Technical University of Denmark, and the Instituto Clodomiro Picado of the University of Costa Rica describing the development of a panel of human antibodies that neutralise elements of black mamba snake toxin in an in vivo model.

	Study uncovers rare phenomenon of antibodies working together against malaria Scientists investigating how the human immune system defends against malaria have uncovered a rare phenomenon: antibodies working together to bind to a vulnerable spot on the parasite.